Bishal Gyawali: Here is a list of our top 10 publications from 2023
Bishal Gyawali, Medical Oncologist and Assistant Professor at Queen’s University, shared on X:
“Happy New Year 2024. If you’re looking for some year-end reading, here is a list of our top 10 publications from 2023:
1. CSO (Common Sense Oncology) manifesto, The Lancet Oncology.
2. Accelerated Approval Program for Cancer Drugs, NEJM.
3. HTA Assessment for cancer drugs across high-income countries, The Lancet Oncology.
4. Problematic crossovers in cancer drug trials, Nature Reviews Clinical Oncology.
5. Relation between price and clinical benefit of cancer drugs in Canada, JAMA Network Open.
6. Immunotherapy in pre-patients, JAMA Oncology.
7. PFS as the primary endpoint for registration trials, Journal of Clinical Oncology.
8. How to evaluate adjuvant therapy trials? Journal of Clinical Oncology.
9. On informative censoring in the context of MonarchE trial, The Lancet Oncology.
10. Role of colonoscopy screening in the context of the NordICC trial: is it the trial or the procedure that failed? eClinicalMedicine – The Lancet Discovery Science.